As #innovations in computer hardware and software begin to plateau, investors are turning to healthcare – particularly #biotech and #pharma – as the next wave of high-impact, high-return opportunities.

Over the past decade, the clinical trials market has gone from a market size of $5.3 billion in 2012 to $37 billion per year in 2021, and from an average deal size of $10 million in 2012 to an estimated $40 million by end 2022. Development is a capital-intensive business and the risks are high.

Investors need insight into both the funding history and the pipeline of potential drug development.

Few industries require such a huge upfront capital before generating revenue.

Clinical trials can take years and carry increased risks.

#Investors have little to no recourse if clinical trials produce negative results, making it essential to identify opportunities with a high probability of #success.

Learn more about our clinical trial and funding data here ️ https://get.pitchbook.com/pitchbook-free-trial-clinical-trials/?utm_medium=social&utm_source=youtube&utm_campaign=market_intel&utm_content=q4_2022_clinicaltrials&utm_term=innovations

Please take the opportunity to connect and share this video with your friends and family if you find it helpful.